Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 79, 2019 - Issue 1-2
Submit an article Journal homepage
2,929
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

Peter Ridefelta Department of Medical Sciences, Uppsala University, Uppsala, Sweden; View further author information
,
Emil Hagströma Department of Medical Sciences, Uppsala University, Uppsala, Sweden; ;b Uppsala Clinical Research Centre, Uppsala, SwedenView further author information
,
Maria K. Svenssona Department of Medical Sciences, Uppsala University, Uppsala, Sweden; View further author information
,
Torbjörn Åkerfeldta Department of Medical Sciences, Uppsala University, Uppsala, Sweden; ORCID Iconhttps://orcid.org/0000-0003-0214-596XView further author information
ORCID Icon &
Anders Larssona Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
View further author information
Pages 39-42 | Received 10 Jul 2018, Accepted 18 Nov 2018, Published online: 12 Jan 2019

References

  • Roth GA, Johnson CO, Abate KH, et al. The burden of cardiovascular diseases among US States, 1990–2016. JAMA Cardiol. 2018;3:375–389.
  • Ballantyne CM, Hoogeveen RC. Role of lipid and lipoprotein profiles in risk assessment and therapy. Am Heart J. 2003;146:227–233.
  • Averna M, Stroes E, Ogura M, et al. How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL. Atheroscler Suppl. 2017;26:16–24.
  • Blaha MJ, Blumenthal RS, Brinton EA, et al. The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol. 2008;2:267–273.
  • Bergmann K. Non-HDL cholesterol and evaluation of cardiovascular disease risk. Ejifcc. 2010;21:64–67.
  • Meeusen JW, Donato LJ, Jaffe AS. Lipid biomarkers for risk assessment in acute coronary syndromes. Curr Cardiol Rep. 2017;19:48.
  • Langlois MR, Chapman MJ, Cobbaert C, et al. Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A Consensus Statement from EAS and EFLM. Clin Chem. 2018;64:1006–1033.
  • Cederholm J, Eliasson B, Zethelius B, et al. Risk factors for cardiovascular disease. Results from the Swedish national diabetes register compared with international studies. Lakartidningen. 2013;110:882–885.
  • Felding P, Rustad P, Martensson A, et al. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest. 2004;64:327–342.
  • Henriksen GM, Pedersen MM, Norgaard I, et al. Minimally processed fresh frozen human reference sera: preparation, testing, and application to international external quality assurance. Scand J Clin Lab Invest. 2004;64:293–308.
  • Rustad P, Felding P, Franzson L, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest. 2004;64:271–284.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
  • Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med. 2004;42:710–714.
  • Solberg HE. RefVal: a program implementing the recommendations of the International Federation of Clinical Chemistry on the statistical treatment of reference values. Comput Methods Programs Biomed. 1995;48:247–256.
  • Lahti A, Hyltoft PP, Boyd JC, et al. Objective criteria for partitioning Gaussian-distributed reference values into subgroups. Clin Chem. 2002;48:338–352.
  • Jepsen AM, Langsted A, Varbo A, et al. Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease. Clin Chem. 2016;62:593–604.
  • Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cutpoints – a Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2016;62:930–946.
  • Larsson A, Hagstrom E, Nilsson L, et al. Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol. Ups J Med Sci. 2018;1–6.
  • Rustad P, Simonsson P, Felding P, et al. Nordic Reference Interval Project Bio-bank and Database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals. Scand J Clin Lab Invest. 2004;64:431–438.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.